Procter & Gamble SEC Filings

Procter & Gamble Company (PG) Form 144 notice reports a proposed sale of 7,230 shares of common stock through Morgan Stanley Smith Barney LLC on 08/19/2025 with an aggregate market value of $1,119,963.15. The shares were acquired the prior day, 08/18/2025, as a Performance Stock Program Award from The Procter & Gamble Company and payment was recorded on 08/18/2025. The filing lists total shares outstanding as 2,342,371,488. The filer certifies no undisclosed material adverse information and provides signature and legal attestations required by the form.

Form 144 notice from an insider at The Procter & Gamble Company (PG) reports a proposed sale of 11,578 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $1,793,490.09 and approximately 2,342,371,488 shares outstanding. The securities were acquired on 08/18/2025 as a Performance Stock Program Award and payment was recorded on the same date. The filer states there have been no sales by the person in the past three months and affirms no undisclosed material adverse information is known. This filing is a routine Rule 144 notice indicating the intention to sell company shares by an insider and does not include broader financial results or operational details.

Procter & Gamble Company (PG) filing a Form 144 notifies the proposed sale of 13,677 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $2,118,635.69. The shares were acquired on 08/18/2025 as a Performance Stock Program Award from The Procter & Gamble Company and payment/vesting is recorded on 08/18/2025. The approximate date of sale listed is 08/19/2025. The filer indicates there have been no sales in the past three months and attests to possessing no undisclosed material adverse information.

Procter & Gamble Company (PG) Form 144 notice discloses a proposed sale of 12,353 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $1,913,541.47. The shares are reported as acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company, with an approximate sale date of 08/19/2025. The filing lists 2,342,371,488 shares outstanding for the class. No securities of the issuer were reported sold by the person in the prior three months. The filer represents there is no undisclosed material adverse information and notes the criminal penalties for misstatement.

The filing is a Form 144 notice reporting a proposed sale of 10,094 shares of Procter & Gamble Company common stock through Morgan Stanley Smith Barney LLC on the New York Stock Exchange, with an aggregate market value of $1,563,611.07, and an approximate sale date of 08/19/2025. The shares were acquired on 08/18/2025 under a Performance Stock Program Award from Procter & Gamble and 21,372 shares are shown as the amount acquired on that date for the award. The filer represents they are not aware of any undisclosed material adverse information about the issuer.

Form 144 filed for Procter & Gamble Company (PG). The filer notified intent to sell 15,328 shares of common stock through Morgan Stanley Smith Barney LLC on 08/19/2025, with an aggregate market value of $2,374,383.84. The shares were acquired on 08/18/2025 as a Performance Stock Program Award from The Procter & Gamble Company, totaling 30,815 shares received and showing 2,342,371,488 shares outstanding. The filer reported no sales in the past three months and included the standard representation that they are not aware of undisclosed material adverse information. The notice indicates the transaction will be executed on the NYSE.

Form 144 notice for Procter & Gamble (PG) shows a proposed sale of 376 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $58,244.28 and approximately 2,342,371,488 shares outstanding. The securities were acquired on 08/18/2025 as a Performance Stock Program Award from The Procter & Gamble Company and payment was recorded on 08/18/2025. No securities of the issuer were reported sold by the filer in the past three months. The filer affirms they are not aware of undisclosed material adverse information about the issuer.

Procter & Gamble Company (PG) Form 144 notice: The filer notified intent to sell 10,686 shares of Procter & Gamble common stock through Morgan Stanley Smith Barney on 08/19/2025 on the NYSE. The filing lists an aggregate market value of $1,655,314.83 and reports 2,342,371,488 shares outstanding. The shares to be sold were acquired on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company; the acquisition quantity is reported as 22,496 shares with payment on 08/18/2025. The filer attests there is no undisclosed material adverse information and includes the standard signature and criminal-penalty notice applicable to Form 144.

Procter & Gamble (PG) filing a Rule 144 notice shows a proposed sale of company common stock through Morgan Stanley Smith Barney LLC on 08/19/2025. The notice lists two lots: 929 shares with an aggregate market value of $143,906.75 and 12,963 shares with an aggregate market value of $2,008,033.52. The total outstanding shares reported for the issuer are 2,342,371,488, making the proposed sale a vanishingly small fraction of the company’s float.

The securities were acquired on 08/18/2025 as Performance Stock Program awards from The Procter & Gamble Company and payment/consideration is listed as NA. The filer certifies there are no known undisclosed material adverse facts and reports no securities sold by the person in the past three months.